Sökning: id:"swepub:oai:DiVA.org:liu-198864" >
Drugs with a negati...
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients
-
- Hafez, Gaye (författare)
- Altinbas Univ, Turkiye
-
- Malyszko, Jolanta (författare)
- Med Univ Warsaw, Poland
-
- Golenia, Aleksandra (författare)
- Med Univ Warsaw, Poland
-
visa fler...
-
- Klimkowicz-Mrowiec, Aleksandra (författare)
- Jagiellonian Univ Med Coll, Poland
-
- Ferreira, Ana Carina (författare)
- Ctr Hosp & Univ Lisboa Cent, Portugal; Univ Nova Lisboa, Portugal
-
- Arici, Mustafa (författare)
- Hacettepe Univ, Turkiye
-
- Bruchfeld, Annette (författare)
- Karolinska Institutet,Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Univ Hosp, Sweden; CLINTEC Karolinska Inst, Sweden
-
- Nitsch, Dorothea (författare)
- London Sch Hyg & Trop Med, England
-
- Massy, Ziad A. (författare)
- Paris Saclay Univ, France; Ambroise Pare Univ, France
-
- Pepin, Marion (författare)
- Ambroise Pare Univ, France; Ambroise Pare Univ, France
-
- Capasso, Giovambattista (författare)
- Univ Campania Luigi Vanvitelli, Italy; Biogem Res Inst, Italy
-
- Mani, Laila-Yasmin (författare)
- Univ Bern, Switzerland
-
- Liabeuf, Sophie (författare)
- Amiens Univ Med Ctr, France; Jules Verne Univ Picardie, France
-
visa färre...
-
(creator_code:org_t)
- OXFORD UNIV PRESS, 2023
- 2023
- Engelska.
-
Ingår i: Clinical Kidney Journal. - : OXFORD UNIV PRESS. - 2048-8505 .- 2048-8513. ; 16:12, s. 2378-2392
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://liu.diva-por... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- There is growing evidence that chronic kidney disease (CKD) is an independent risk factor for cognitive impairment, especially due to vascular damage, blood-brain barrier disruption and uremic toxins. Given the presence of multiple comorbidities, the medication regimen of CKD patients often becomes very complex. Several medications such as psychotropic agents, drugs with anticholinergic properties, GABAergic drugs, opioids, corticosteroids, antibiotics and others have been linked to negative effects on cognition. These drugs are frequently included in the treatment regimen of CKD patients. The first review of this series described how CKD could represent a risk factor for adverse drug reactions affecting the central nervous system. This second review will describe some of the most common medications associated with cognitive impairment (in the general population and in CKD) and describe their effects. Graphical Abstract
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- adverse drug reaction; chronic kidney disease; cognitive impairment; drug prescription; medications
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Hafez, Gaye
-
Malyszko, Jolant ...
-
Golenia, Aleksan ...
-
Klimkowicz-Mrowi ...
-
Ferreira, Ana Ca ...
-
Arici, Mustafa
-
visa fler...
-
Bruchfeld, Annet ...
-
Nitsch, Dorothea
-
Massy, Ziad A.
-
Pepin, Marion
-
Capasso, Giovamb ...
-
Mani, Laila-Yasm ...
-
Liabeuf, Sophie
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
Clinical Kidney ...
- Av lärosätet
-
Linköpings universitet
-
Karolinska Institutet